en · de · es · fr · pt
sr9009-notes.peptides6088.com › Blog › Identity, Handling, And Regulation — Research Overview

Identity, Handling, And Regulation — Research Overview

By Editorial Desk · published 2025-08-14 · last reviewed 2025-09-23 · Blog

anti-doping is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2025-09-23. Where a claim depends on a specific study, the study is described rather than over-claimed.

Identity, Handling, and Regulation

Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.

In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.

Handling Storage and Quality Control

Storage conditions for research-grade SR9009 generally involve a freezer at approximately minus twenty degrees Celsius, sometimes lower for long-term preservation. Containers should remain tightly closed and protected from light. Desiccants may be used to limit moisture uptake. Solutions are often stored in aliquots to avoid repeated warming and cooling. Stability data for the compound under various conditions are limited, so laboratories typically follow supplier recommendations and verify performance through periodic analytical checks rather than assuming indefinite stability.

Identity and purity testing for SR9009 commonly uses liquid chromatography coupled with tandem mass spectrometry. This method separates the compound from matrix components and detects it by mass-to-charge transitions, providing sensitive and specific confirmation. Nuclear magnetic resonance spectroscopy can support structural identification, while high-performance liquid chromatography with ultraviolet detection may estimate purity. Because online products labeled as SR9009 may contain other substances or no active compound at all, independent verification is important in research settings. Certificates of analysis are useful but not a substitute for in-house testing.

Laboratory samples of SR9009 are typically supplied as a white to off-white powder. The compound dissolves readily in organic solvents such as dimethyl sulfoxide and ethanol, while its solubility in water is low. Because of this solubility profile, researchers often prepare concentrated stock solutions in an organic solvent before diluting them into aqueous assay buffers. Light exposure, moisture, and repeated freeze-thaw cycles can degrade many small molecules, so handling procedures usually aim to minimize these factors. Purity is commonly checked before use.

Sr9009 at a glance

PropertyValueNotes
AppearanceWhite to off-white solidVisual inspection is not sufficient for identity.
SolubilitySoluble in DMSO and ethanolLow solubility in water.
Typical storage-20 °C, desiccated, darkProtect from repeated temperature changes.
Common analytical methodLC-MS or HPLC-UVReference standard required for comparison.
Common synonymsSR9009; Stenabolic; REV-ERB agonistVendor naming may vary.

Handling, Analysis, and Regulation

Regulatory treatment of SR9009 varies by country and context. It is not approved as a therapeutic drug by agencies such as the United States Food and Drug Administration or the European Medicines Agency. Sports authorities list it as a prohibited substance; the World Anti-Doping Agency classifies it among hormone and metabolic modulators. Legal status for personal possession or sale differs across jurisdictions, and some countries may restrict it under analog or research chemical laws. Buyers who seek verified material often rely on independent laboratory testing because online product labels may not match contents.

Laboratory samples of SR9009 are typically handled as research chemicals rather than pharmaceuticals. Suppliers usually state that the material is for research use only and not for human or veterinary administration. Storage recommendations generally call for a freezer at approximately −20 °C, protection from light, and a desiccated environment. The solid is often described as a white to off-white powder. Solubility is commonly reported in organic solvents such as dimethyl sulfoxide and ethanol, with low solubility in water.

Related pages on this site

SR9009 Background and Receptor Mechanism

SR9009 binds REV-ERB receptors and alters their repressive activity on target genes. This action can change transcription of genes involved in lipid handling, glucose metabolism, and mitochondrial function. In rodent studies, treated animals have shown changes in muscle oxidative capacity and exercise performance, though effects vary by dose, duration, and model. The precise molecular steps connecting receptor binding to whole-body outcomes are still an active area of investigation. Findings in animals do not automatically translate to humans.

Because REV-ERB receptors are core clock components, SR9009 has been examined for effects on daily rhythms as well as metabolism. Research has explored whether the compound can shift or reinforce circadian gene expression in tissues such as liver and muscle. Some studies report improved metabolic markers in obese or diabetic mice, while others show context-dependent responses. Questions remain about which effects are direct, which are secondary to timing, and how they might differ across species.

Background and Research Status

Most published work on SR9009 consists of preclinical studies. It is widely sold as a research chemical, a category that does not imply safety, efficacy, or pharmaceutical-grade quality. Sports anti-doping organizations have listed SR9009 as a prohibited substance, and its presence in an athlete sample can lead to sanctions. Legal status differs by country; in several jurisdictions it is not approved for human consumption and may be treated as an unapproved new drug.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not a steroid, peptide, or natural hormone. In scientific literature, it appears under the code SR9009 and in non-scientific contexts as Stenabolic. The compound was identified through chemical screening efforts aimed at targeting circadian clock components. Its status remains investigational, and no regulatory agency has approved it as a human medicine.

Supporting material

The African continent was bled of its human resources via all possible routes. Across the Sahara, through the Red Sea, from the Indian Ocean ports and across the Atlantic. At least ten centuries of slavery for the benefit of the Muslim countries (from the ninth to the nineteenth).... Four million enslaved people exported via the Red Sea, another four million through the Swahili ports of the Indian Ocean, perhaps as many as nine million along the trans-Saharan caravan route, and eleven to twenty million (depending on the author) across the Atlantic Ocean. The trans-Atlantic slave trade peaked in the late 18th century, when the largest number of slaves were captured on raiding expeditions into the interior of West Africa. These expeditions were typically carried out by African kingdoms, such as the Oyo Empire (Yoruba), the Ashanti Empire, the kingdom of Dahomey, and the Aro Confederacy. It is estimated that about 15 percent of slaves died during the voyage, with mortality rates considerably higher in Africa itself in the process of capturing and transporting indigenous peoples to the ships. Mauritania was the last country in the world to officially ban slavery, in 1981, with legal prosecution of slaveholders established in 2007.

==== Danish ==== Danish Brotherhood in America Danish Sisterhood - Founded December 15, 1883, in Negaunee, Michigan, by Mrs. Christine Hemmingsen. A supreme lodge was formed in 1887, and all the officers were women by 1910. Membership was open to women of Danish descent or married to a man of Danish descent. Admission is by black ball, with one blackball enough to disqualify; there is always a second ballot; if there is another blackball a selected secret committee is appointed to determine the cause. Had a secret ritual, and no uninitiated person may attend secret meetings of the lodge. Locals are called "lodges"; regional groups are called "Districts". National convention meets quadrennially. Supreme Lodge headquarters is in Chicago. Provides funeral benefits of up to $1,000, no more than two beneficiaries can be designated, and in special circumstances, other benefits can be applied for. Membership in 1922, 8,000, 1934, 7,000, and 1979, 4,500.

Using the co-ordinates of the subunits and segments to determine the topographic location of the defect on the nose, the plastic surgeon plans, maps, and executes a rhinoplasty procedure. The unitary division of the nasal topography permits minimal, but precise, cutting, and maximal corrective-tissue coverage, to produce a functional nose of proportionate size, contour, and appearance for the patient. Hence, if more than 50 percent of an aesthetic subunit is lost (damaged, defective, destroyed) the surgeon replaces the entire aesthetic segment, usually with a regional tissue graft, harvested from either the face or the head, or with a tissue graft harvested from elsewhere on the patient's body.

The enyzme cyclises nicotinamide adenine dinucleotide (a cation) to give initially nicotinamide and cyclic ADP-ribose as intermediate. The latter is then hydrolyzed to adenosine diphosphate ribose (ADP-ribose). This makes it different from NAD+ glycohydrolase (EC 3.2.2.5), where the hydrolysis gives ADP-ribose directly. The enzyme was characterised from beef spleen. The enzyme is also present in bacteria and humans. This enzyme is a hydrolase, specifically a glycosylase that hydrolyses N-glycosyl compounds. Other names of this enzyme include nicotinamide adenine dinucleotide (phosphate) nucleosidase, triphosphopyridine nucleotidase, NAD(P) nucleosidase, NAD(P)ase, and nicotinamide adenine dinucleotide (phosphate) glycohydrolase.

Sources: en.wikipedia.org

Notes from published material

== Effects of ingestion == Datura is considered a deliriant. Due to the potent combination of anticholinergic substances it contains, Datura intoxication typically produces the effects of anticholinergic delirium (usually involving a complete or relative inability to differentiate reality from fantasy); bizarre thoughts, hyperthermia; tachycardia; bizarre and possibly violent behavior; dry skin; dry mouth; illusions; and severe mydriasis (dilated pupils) with resultant painful photophobia that can last several days. Muscle stiffness, urinary retention, temporary paralysis, disrobing, emotional bluntness, dysphoria and confusion are often reported, and pronounced amnesia is another commonly reported effect. The psychoactive alkaloids scopolamine and atropine are also both known for their characteristic hyperactive effects and ability to cause stark and dream-like hallucinations. The onset of symptoms generally occurs around 30 to 60 minutes after ingesting the herb. These symptoms generally last from 24 to 48 hours, but have been reported in some cases to last two weeks or longer.

=== Patent protection and litigation === The original patent, U.S. patent 4,927,855, was granted to Laboratoire L. Lafon in 1990, covering the chemical compound of modafinil. This patent expired in 2010. In 1994, Cephalon filed a patent for modafinil in the form of particles of a defined size, represented by U.S. patent 5,618,845, which expired in 2015. Following the nearing expiration of marketing rights in 2002, generic manufacturers, including Mylan and Teva, applied for US Food and Drug Administration approval to market a generic form of modafinil, leading to legal challenges by Cephalon regarding the particle size patent. The patent RE 37,516 was declared invalid and unenforceable in 2011. In addition, Cephalon entered agreements with several generic drug manufacturers to delay the sale of generic modafinil in the US. These agreements were subject to legal scrutiny and antitrust investigations, culminating in a ruling by the Court of Appeals in 2016, which found that the settlements did not violate antitrust laws.

=== Determining ileal digestibility === While more accurate, the determination of ileal digestibility of various protein sources requires human or porcine subjects, making research much more difficult than in mice. While the body of research on food ileal digestibilities has grown since the introduction of the DIAAS, as of 2025, more research is still needed, particularly on foods outside of Western or Eastern diets.

Fluid dynamics is a subdiscipline of fluid mechanics that deals with fluid flow—the science of liquids and gases in motion. Fluid dynamics offers a systematic structure—which underlies these practical disciplines—that embraces empirical and semi-empirical laws derived from flow measurement and used to solve practical problems. The solution to a fluid dynamics problem typically involves calculating various properties of the fluid, such as velocity, pressure, density, and temperature, as functions of space and time. It has several subdisciplines itself, including aerodynamics (the study of air and other gases in motion) and hydrodynamics (the study of liquids in motion). Fluid dynamics has a wide range of applications, including calculating forces and moments on aircraft, determining the mass flow rate of petroleum through pipelines, predicting evolving weather patterns, understanding nebulae in interstellar space and modeling explosions. Some fluid-dynamical principles are used in traffic engineering and crowd dynamics.

Shortly after the show-cause notices were issued, Essendon and James Hird challenged the legal validity of the joint investigation that ASADA had conducted with the AFL, temporarily putting the notices on hold. The club argued that although AFL rules allowed it to compel its players and officials to be interviewed, ASADA had no legal right to do the same – and therefore that evidence collected by the AFL in a compulsory interview was inadmissible for an ASADA investigation. The case came before the Melbourne division of the Federal Court of Australia on 27 June 2014; and on 19 September 2014, Justice John Middleton of the Federal Court dismissed the challenge and found investigation to be lawful. In the decision, he ruled that ASADA had actively used the AFL's power to compel interviews to overcome its own inability to do likewise; but, that this was within the rule of law and with the Essendon players' knowledge, because all interviews were knowingly held in the presence of an ASADA representative. On 1 October 2014, Essendon announced that it would not appeal the ruling, stating that to do so would act against the interests of the players. Hird, however, acting in an individual capacity and "on a matter of principle", appealed the ruling to a full bench of the Federal Court. Media commentators speculated that Hird's action would result in his termination as Essendon coach, and Hird himself later testified in court that he had been advised as much, but this did not occur and he remained to coach in 2015.

Sources: en.wikipedia.org

Frequently asked questions

How is SR9009 usually analyzed?

Liquid chromatography–mass spectrometry is common for identity and purity checks. High-performance liquid chromatography with ultraviolet detection can also be used. Both methods require a suitable reference standard.

What storage conditions are typical?

The solid is usually kept desiccated at -20 °C or lower and protected from light. Stock solutions are aliquoted to limit freeze–thaw cycles. Aqueous solutions are not generally recommended for long-term storage.

Is SR9009 legal to purchase?

Laws differ by country and by intended use. It is not an approved medicine, and many vendors sell it as a research chemical. Purchasers are responsible for confirming local restrictions.

How should SR9009 be stored?

Research-grade SR9009 is typically stored frozen at about minus twenty degrees Celsius, protected from light and moisture. Stock solutions are often kept in aliquots to avoid repeated freeze-thaw cycles. Specific storage conditions should follow the supplier's documentation.

Network